StockNow
CalendarLog in
U.S. Markets

Cencora (COR) says management is confident momentum will continue into FY27, supported by speciality pharma; detailed FY27 guidance to be provided in November

StockNow breaking-news AI analysis

Cencora expressed confidence in continuing business momentum into FY27 driven by specialty pharma, with full detailed fiscal 2027 guidance scheduled for release during its November call.

1 stocks
CORCencora, Inc.$322.70Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
U.S. Economy

US ADP Employment Change Weekly 16.25K (Prev. 12K)

Politics

Libya's NOC says production and operations have been suspended in 3 oil fields after a valve was closed on the Al-Hamada-Zawiya pipeline, may need to declare force majeure if its remains closed

Commodities

Saudi Arabia is reportedly informing some European oil refiners that their Sep' loading of crude cargoes are cancelled, according to sources